Citi Initiates SpaceX at Buy, $200 Price Target

1 min read Reproduced verbatim
Rating
Buy
New coverage
Target
$200
First target
Upside
+44%
SPCX at $139 today

Citi’s latest target on SpaceX is now $240 (Oct 21, 2026); the median of 29 firms is $240. Citi has reached 88% of its year-old targets (43 scored).

Citi and SpaceX logos

What the analyst said

Citi analyst John Godyn initiates coverage on SpaceX (NASDAQ: SPCX) with a Buy rating and a price target of $200.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

SPCX trades at $139. The 29 analysts who set a target in the last 3 months range from $75 to $800, with a median of $240. This $200 target is 17% below the median.

Since the note SPCX has moved −13% (from $160). 12-month window: day 131 of 365, closes on July 7, 2027.

Track record

This callOpen: SPCX has not reached $200 yet. This 12-month target is scored on July 7, 2027.

Firm track recordCiti: 88% of its 43 targets at least a year old were reached within 12 months (#3 of 28 firms). Accuracy ranking →

Citi on SpaceX

Citi price targets on SpaceX

2 calls from July 7, 2026 to October 21, 2026. The target went from $200 to $240 (+20%). The rating stayed Buy.

Citi targetSPCX share price
  1. October 21, 2026Target raised from $200 (+20%)Buy$240
  2. July 7, 2026 This noteEarliest call shownBuy$200
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.